These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27185198)

  • 21. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine mapping in TERT-CLPTM1L region identified three independent lung cancer susceptibility signals: A large-scale multi-ethnic population study.
    Li Z; Pu Z; Fan J; Li N; Zhu M; Zhang J; Wang Y; Geng L; Cheng Y; Ma H; Jin G; Dai J; Hu Z; Shen H
    Mol Carcinog; 2018 Oct; 57(10):1289-1299. PubMed ID: 29809284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry.
    Bei JX; Su WH; Ng CC; Yu K; Chin YM; Lou PJ; Hsu WL; McKay JD; Chen CJ; Chang YS; Chen LZ; Chen MY; Cui Q; Feng FT; Feng QS; Guo YM; Jia WH; Khoo AS; Liu WS; Mo HY; Pua KC; Teo SH; Tse KP; Xia YF; Zhang H; Zhou GQ; Liu JJ; Zeng YX; Hildesheim A;
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):188-192. PubMed ID: 26545403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.
    Myung JK; Kwak BK; Lim JA; Lee MC; Kim MJ
    Cancer Res Treat; 2016 Jul; 48(3):942-7. PubMed ID: 26727717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair.
    Yee Ko JM; Dai W; Wun Wong EH; Kwong D; Tong Ng W; Lee A; Kai Cheong Ngan R; Chung Yau C; Tung S; Li Lung M
    Int J Cancer; 2014 Oct; 135(7):1634-45. PubMed ID: 24615621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.
    Mocellin S; Verdi D; Pooley KA; Landi MT; Egan KM; Baird DM; Prescott J; De Vivo I; Nitti D
    J Natl Cancer Inst; 2012 Jun; 104(11):840-54. PubMed ID: 22523397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of NRG1 in the Predisposition to Papillary Thyroid Carcinoma.
    He H; Li W; Liyanarachchi S; Wang Y; Yu L; Genutis LK; Maharry S; Phay JE; Shen R; Brock P; de la Chapelle A
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1369-1379. PubMed ID: 29121253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
    Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
    Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.
    Zienolddiny S; Skaug V; Landvik NE; Ryberg D; Phillips DH; Houlston R; Haugen A
    Carcinogenesis; 2009 Aug; 30(8):1368-71. PubMed ID: 19465454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma.
    Liu Y; Shi F
    Eur J Cancer Prev; 2020 May; 29(3):259-265. PubMed ID: 31651569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
    Wang Z; Zhu B; Zhang M; Parikh H; Jia J; Chung CC; Sampson JN; Hoskins JW; Hutchinson A; Burdette L; Ibrahim A; Hautman C; Raj PS; Abnet CC; Adjei AA; Ahlbom A; Albanes D; Allen NE; Ambrosone CB; Aldrich M; Amiano P; Amos C; Andersson U; Andriole G; Andrulis IL; Arici C; Arslan AA; Austin MA; Baris D; Barkauskas DA; Bassig BA; Beane Freeman LE; Berg CD; Berndt SI; Bertazzi PA; Biritwum RB; Black A; Blot W; Boeing H; Boffetta P; Bolton K; Boutron-Ruault MC; Bracci PM; Brennan P; Brinton LA; Brotzman M; Bueno-de-Mesquita HB; Buring JE; Butler MA; Cai Q; Cancel-Tassin G; Canzian F; Cao G; Caporaso NE; Carrato A; Carreon T; Carta A; Chang GC; Chang IS; Chang-Claude J; Che X; Chen CJ; Chen CY; Chen CH; Chen C; Chen KY; Chen YM; Chokkalingam AP; Chu LW; Clavel-Chapelon F; Colditz GA; Colt JS; Conti D; Cook MB; Cortessis VK; Crawford ED; Cussenot O; Davis FG; De Vivo I; Deng X; Ding T; Dinney CP; Di Stefano AL; Diver WR; Duell EJ; Elena JW; Fan JH; Feigelson HS; Feychting M; Figueroa JD; Flanagan AM; Fraumeni JF; Freedman ND; Fridley BL; Fuchs CS; Gago-Dominguez M; Gallinger S; Gao YT; Gapstur SM; Garcia-Closas M; Garcia-Closas R; Gastier-Foster JM; Gaziano JM; Gerhard DS; Giffen CA; Giles GG; Gillanders EM; Giovannucci EL; Goggins M; Gokgoz N; Goldstein AM; Gonzalez C; Gorlick R; Greene MH; Gross M; Grossman HB; Grubb R; Gu J; Guan P; Haiman CA; Hallmans G; Hankinson SE; Harris CC; Hartge P; Hattinger C; Hayes RB; He Q; Helman L; Henderson BE; Henriksson R; Hoffman-Bolton J; Hohensee C; Holly EA; Hong YC; Hoover RN; Hosgood HD; Hsiao CF; Hsing AW; Hsiung CA; Hu N; Hu W; Hu Z; Huang MS; Hunter DJ; Inskip PD; Ito H; Jacobs EJ; Jacobs KB; Jenab M; Ji BT; Johansen C; Johansson M; Johnson A; Kaaks R; Kamat AM; Kamineni A; Karagas M; Khanna C; Khaw KT; Kim C; Kim IS; Kim JH; Kim YH; Kim YC; Kim YT; Kang CH; Jung YJ; Kitahara CM; Klein AP; Klein R; Kogevinas M; Koh WP; Kohno T; Kolonel LN; Kooperberg C; Kratz CP; Krogh V; Kunitoh H; Kurtz RC; Kurucu N; Lan Q; Lathrop M; Lau CC; Lecanda F; Lee KM; Lee MP; Le Marchand L; Lerner SP; Li D; Liao LM; Lim WY; Lin D; Lin J; Lindstrom S; Linet MS; Lissowska J; Liu J; Ljungberg B; Lloreta J; Lu D; Ma J; Malats N; Mannisto S; Marina N; Mastrangelo G; Matsuo K; McGlynn KA; McKean-Cowdin R; McNeill LH; McWilliams RR; Melin BS; Meltzer PS; Mensah JE; Miao X; Michaud DS; Mondul AM; Moore LE; Muir K; Niwa S; Olson SH; Orr N; Panico S; Park JY; Patel AV; Patino-Garcia A; Pavanello S; Peeters PH; Peplonska B; Peters U; Petersen GM; Picci P; Pike MC; Porru S; Prescott J; Pu X; Purdue MP; Qiao YL; Rajaraman P; Riboli E; Risch HA; Rodabough RJ; Rothman N; Ruder AM; Ryu JS; Sanson M; Schned A; Schumacher FR; Schwartz AG; Schwartz KL; Schwenn M; Scotlandi K; Seow A; Serra C; Serra M; Sesso HD; Severi G; Shen H; Shen M; Shete S; Shiraishi K; Shu XO; Siddiq A; Sierrasesumaga L; Sierri S; Loon Sihoe AD; Silverman DT; Simon M; Southey MC; Spector L; Spitz M; Stampfer M; Stattin P; Stern MC; Stevens VL; Stolzenberg-Solomon RZ; Stram DO; Strom SS; Su WC; Sund M; Sung SW; Swerdlow A; Tan W; Tanaka H; Tang W; Tang ZZ; Tardon A; Tay E; Taylor PR; Tettey Y; Thomas DM; Tirabosco R; Tjonneland A; Tobias GS; Toro JR; Travis RC; Trichopoulos D; Troisi R; Truelove A; Tsai YH; Tucker MA; Tumino R; Van Den Berg D; Van Den Eeden SK; Vermeulen R; Vineis P; Visvanathan K; Vogel U; Wang C; Wang C; Wang J; Wang SS; Weiderpass E; Weinstein SJ; Wentzensen N; Wheeler W; White E; Wiencke JK; Wolk A; Wolpin BM; Wong MP; Wrensch M; Wu C; Wu T; Wu X; Wu YL; Wunder JS; Xiang YB; Xu J; Yang HP; Yang PC; Yatabe Y; Ye Y; Yeboah ED; Yin Z; Ying C; Yu CJ; Yu K; Yuan JM; Zanetti KA; Zeleniuch-Jacquotte A; Zheng W; Zhou B; Mirabello L; Savage SA; Kraft P; Chanock SJ; Yeager M; Landi MT; Shi J; Chatterjee N; Amundadottir LT
    Hum Mol Genet; 2014 Dec; 23(24):6616-33. PubMed ID: 25027329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
    Li JJ; Zheng PCJ; Wang YZ
    World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk.
    Pande M; Spitz MR; Wu X; Gorlov IP; Chen WV; Amos CI
    Carcinogenesis; 2011 Oct; 32(10):1493-9. PubMed ID: 21771723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF
    Nasirden A; Saito T; Fukumura Y; Hara K; Akaike K; Kurisaki-Arakawa A; Asahina M; Yamashita A; Tomomasa R; Hayashi T; Arakawa A; Yao T
    Virchows Arch; 2016 Dec; 469(6):687-696. PubMed ID: 27718012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
    Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
    Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer susceptibility locus at 5p15.33.
    McKay JD; Hung RJ; Gaborieau V; Boffetta P; Chabrier A; Byrnes G; Zaridze D; Mukeria A; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Bencko V; Foretova L; Janout V; McLaughlin J; Shepherd F; Montpetit A; Narod S; Krokan HE; Skorpen F; Elvestad MB; Vatten L; Njølstad I; Axelsson T; Chen C; Goodman G; Barnett M; Loomis MM; Lubiñski J; Matyjasik J; Lener M; Oszutowska D; Field J; Liloglou T; Xinarianos G; Cassidy A; ; Vineis P; Clavel-Chapelon F; Palli D; Tumino R; Krogh V; Panico S; González CA; Ramón Quirós J; Martínez C; Navarro C; Ardanaz E; Larrañaga N; Kham KT; Key T; Bueno-de-Mesquita HB; Peeters PH; Trichopoulou A; Linseisen J; Boeing H; Hallmans G; Overvad K; Tjønneland A; Kumle M; Riboli E; Zelenika D; Boland A; Delepine M; Foglio M; Lechner D; Matsuda F; Blanche H; Gut I; Heath S; Lathrop M; Brennan P
    Nat Genet; 2008 Dec; 40(12):1404-6. PubMed ID: 18978790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TERT-rs33963617 and CLPTM1L-rs77518573 reduce the risk of non-small cell lung cancer in Chinese population.
    Ji Z; Li Y; Xiang C; Luo X; Yuan P; Long J; Shen N; Shen Y; Deng L; Li J; Cheng L
    Gene; 2020 Mar; 731():144357. PubMed ID: 31935503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population.
    Zhao MM; Zhang Y; Shen L; Ren YW; Li XL; Yin ZH; Zhou BS
    Asian Pac J Cancer Prev; 2014; 15(6):2809-13. PubMed ID: 24761905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.